|
|
Regulation of eicosanoid signaling lipids to improve skeletal muscle function and increase healthspan during aging |
| 1 R01 AG069858-01 |
BLAU, HELEN M |
NIA |
2020 |
|
|
Enhancement of Aged Skeletal Muscle Contractility and Muscle Quality by Administration of Trimetazidine |
| 1 R03 AG065828-01 |
RUSS, DAVID W |
NIA |
2020 |
|
|
Social Isolation and Loss of Physical Function: Defining a Novel Neuromuscular Phenotype |
| 1 R03 AG067387-01A1 |
ARNOLD, WILLIAM D |
NIA |
2020 |
|
|
Polypharmacy, Potentially Inappropriate Medications, and Adverse Outcomes in Older Adults with Advanced Cancer Receiving Chemotherapy |
| 1 R03 AG067977-01 |
RAMSDALE, ERIKA E |
NIA |
2020 |
|
|
Development of a Wheelchair Maintenance Alert Application for Elderly Wheelchair Users |
| 1 R03 AG069836-01 |
MHATRE, ANAND |
NIA |
2020 |
|
|
Brain Aging, AD and Dementia in Low and Middle Income Countries (LMICs) and Low Resource Settings: Gender, Genetics, Risk Factors, Pathophysiology and Prevention |
| 1 R13 AG066391-01 |
MAESTRE, GLADYS E |
NIA |
2020 |
|
|
Effect of force-based motor repetition on the control and learning of dexterous manipulation |
| 1 R15 AG067792-01 |
FU, QIUSHI |
NIA |
2020 |
|
|
Mechanisms of Inhibition of L-Dopa Induced Dyskinesia (LID) by GPCR Smoothened Activation. |
| 1 R21 AG065682-01 |
KOTTMANN, ANDREAS H |
NIA |
2020 |
|
|
Strategies for Effective Caregiver Communication with Persons with Alzheimers Disease and Other Dementias (SECC-AD) |
| 1 R21 AG066491-01 |
WILLIAMS, KRISTINE N |
NIA |
2020 |
|
|
A personalized medicine approach to the study of monoamine brain systems that underlie the emergence of neuropsychiatric symptoms in person with Alzheimers disease |
| 1 R21 AG067016-01 |
MACHAIRAKI, VASILIKI |
NIA |
2020 |
